What is the Impact Factor of Chemotherapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Chemotherapy is 1.40, ranking in quartile Q4 of Web of Science (SCIE).

Is Chemotherapy indexed in Web of Science or Scopus?

Yes, Chemotherapy is indexed in Web of Science (SCIE, Q4 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.442 (Q3) and an H-index of 64.

Who publishes Chemotherapy and what is the Article Processing Charge (APC)?

Chemotherapy is published by S. Karger AG. The estimated Article Processing Charge (APC) is approximately $3,027 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Chemotherapy?

The official ISO-4 abbreviation of Chemotherapy is "CHEMOTHERAPY". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q4Scopus Q3SCImago #13,194Hybrid

Chemotherapy

Abbreviation (ISO):CHEMOTHERAPY

•

Identifier (ISSN):0009-3157(Print)/1421-9794(Online)

•

Publisher:S. Karger AG

Official Website Submission Portal Compare

Clarivate IF (2026)

1.4↓ -0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Chemotherapy

WoS Q4

Annual Impact Factor Metric

Current (2026):1.4

Scopus SJR & RankScopus Q3

0.442

#13,194

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

64 papers with at least that number of citations each

WoS: SCIE / JCRQ4

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

34articles/year

11.11% Gold OA•84.21% Original Research

Aims & Scope

This journal publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacologic properties of antibacterial, antiviral and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamics properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug-resistance, an increasing problem worldwide.

Topics Covered (Recognized by AI)

Medicine71.4%Biology65.5%Genetics58.4%Chemistry57.6%Biochemistry50.9%Microbiology45.8%Computer science43.5%Antibiotics40%Philosophy33.2%Linguistics32%Geology31.4%Artificial intelligence31.2%Natural language processing31.1%Thesaurus31.1%Paleontology30.4%Bacteria29.4%Information retrieval28.5%Internal medicine26.4%

Primary Research Areas

Medicine Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank287/333

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank295/356

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank271/333

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank287/356

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	287/333	Q4
PHARMACOLOGY & PHARMACY	JCRSCIE	295/356	Q4
ONCOLOGY	JCISCIE	271/333	Q4
PHARMACOLOGY & PHARMACY	JCISCIE	287/356	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF1.4

Articles / Year5

Total Citations0

2025

IF1.7

Articles / Year10

Total Citations8

2024

IF2

Articles / Year28

Total Citations52

2023

IF3.3

Articles / Year34

Total Citations91

2022

IF3.549

Articles / Year41

Total Citations205

Year	Impact Factor	Articles / Year	Total Citations
2026	1.4	5	0
2025	1.7	10	8
2024	2	28	52
2023	3.3	34	91
2022	3.549	41	205
2021	2.544	47	512
2020	1.641	30	273
2019	1.571	41	969
2018	2	54	580
2017	—	49	2,892
2016	—	60	941
2015	—	20	200

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #13,194Scopus Q3SCImago Profile

Scopus Coverage:1960-2025

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q3

0.442

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q3

Citations / Doc (2 years)

1.10

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,027 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations124

3-Year Documents89

Citable Documents87

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ3

Infectious DiseasesQ3

Medicine (miscellaneous)Q3

OncologyQ3

PharmacologyQ3

Pharmacology (medical)Q3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Chemotherapy (abbr: CHEMOTHERAPY, ISSN: 0009-3157) is a peer-reviewed international scholarly journal in the field of Medicine, published by S. Karger AG in Switzerland since 1968. The periodical holds a Journal Impact Factor (JIF) of 1.40, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.442 (Q3), an H-index of 64.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 34 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,027 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.